SEATTLE – An imaging agent discovered by a Washington State University researcher that homes in on prostate cancer will be developed for human clinical trials thanks to a two-year $2 million federal Small Business Innovation Research grant.
By Eric Sorensen, WSU science writer SEATTLE – A neurodegenerative disease drug developed at Washington State University will likely qualify for a federal “fast-track” designation and go into clinical trials next year, said Leen Kawas, CEO of M3 Biotechnology Inc.
By Linda Weiford, WSU News PULLMAN, WASH. – Not only can scorpion venom make us sick, but one forward whip of the creature’s tail delivers a sting that strikes like flame.
SPOKANE, Wash. – Volunteers with type 1 or type 2 diabetes or peripheral vascular disease are needed for clinical research trials under way at the Washington State University College of Pharmacy in Spokane.
PULLMAN, Wash. – Dogs with arthritis are being sought for two studies in veterinary clinical sciences at Washington State University Pullman.